As of 2025-06-30, the EV/EBITDA ratio of Cellectis SA (ALCLS.PA) is -2.55. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALCLS.PA's latest enterprise value is 48.11 mil EUR. ALCLS.PA's TTM EBITDA according to its financial statements is -18.86 mil EUR. Dividing these 2 quantities gives us the above ALCLS.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 2.7x - 7.0x | 3.5x |
| Forward P/E multiples | 6.5x - 10.6x | 9.0x |
| Fair Price | (0.86) - (0.98) | (0.81) |
| Upside | -168.3% - -178.3% | -164.2% |
| Date | EV/EBITDA |
| 2025-06-26 | -3.11 |
| 2025-06-25 | -3.05 |
| 2025-06-24 | -3.11 |
| 2025-06-23 | -3.01 |
| 2025-06-20 | -3.08 |
| 2025-06-19 | -2.89 |
| 2025-06-18 | -2.92 |
| 2025-06-17 | -3.04 |
| 2025-06-16 | -3.01 |
| 2025-06-13 | -3.10 |
| 2025-06-12 | -3.09 |
| 2025-06-11 | -3.16 |
| 2025-06-10 | -3.14 |
| 2025-06-09 | -3.14 |
| 2025-06-06 | -3.13 |
| 2025-06-05 | -3.23 |
| 2025-06-04 | -3.32 |
| 2025-06-03 | -3.36 |
| 2025-06-02 | -3.46 |
| 2025-05-30 | -3.33 |
| 2025-05-29 | -3.45 |
| 2025-05-28 | -3.45 |
| 2025-05-27 | -3.57 |
| 2025-05-26 | -3.62 |
| 2025-05-23 | -3.71 |
| 2025-05-22 | -3.35 |
| 2025-05-21 | -3.37 |
| 2025-05-20 | -3.36 |
| 2025-05-19 | -3.40 |
| 2025-05-16 | -3.45 |
| 2025-05-15 | -3.40 |
| 2025-05-14 | -3.20 |
| 2025-05-13 | -3.33 |
| 2025-05-12 | -3.41 |
| 2025-05-09 | -3.59 |
| 2025-05-08 | -3.59 |
| 2025-05-07 | -3.65 |
| 2025-05-06 | -4.10 |
| 2025-05-05 | -3.90 |
| 2025-05-02 | -3.87 |
| 2025-04-30 | -3.62 |
| 2025-04-29 | -3.59 |
| 2025-04-28 | -3.78 |
| 2025-04-25 | -3.54 |
| 2025-04-24 | -3.57 |
| 2025-04-23 | -3.38 |
| 2025-04-22 | -3.24 |
| 2025-04-17 | -3.41 |
| 2025-04-16 | -3.40 |
| 2025-04-15 | -3.70 |